Executive Director Ruben Mesa, MD, explains the benefits of having access to clinical trials and the cutting-edge capabilities they provide for patients in South Texas.

Mark Bonnen, MD, discusses how Mays Cancer Center’s Medical Management Program integrates primary care into cancer care to better support our patients.

Kate Lathrop, MD, explains the advantages of being able to collaborate as an NCI- designated Cancer Center and produce translational research to improve patient care.

Executive Director Ruben Mesa, MD, shares the impact investigators at the Mays Cancer Center have made playing a lead role in drug development to treat chronic illnesses in cancer patients.

Mark Bonnen, MD, chief medical officer at Mays Cancer Center, announces bone marrow and stem cell transplants will be offered to patients at the new UT Health San Antonio Multispecialty and Research Hospital opening in 2024.

Kate Lathrop, MD, defines the value of having a National Cancer Institute-designated cancer center that serves San Antonio and South Texas.

Find out how Mays Cancer Center is leading cancer research for Latinos and why it’s important for the future of cancer care in South Texas.

Hear what one expert from Mays Cancer Center is saying about the UT Health San Antonio’s Multispecialty and Research Hospital coming to #SanAntonio in late 2024 to meet the community’s #cancer care needs.

Hear medical oncologist, Kate Lathrop, MD, share the value of offering clinical trials to patients and the potential it has to playing a key role in survivorship.

Chief Medical Officer Mark Bonnen, MD, talks about an innovative device used at Mays Cancer Center to help personalize a patient’s radiation treatment and decrease the amount of radiation exposure.